Announcing our newest cancer test. Screen cancer early with Onco-D-clare. Learn more

Frequently Asked Questions

Can a patient order a test/kit themselves?

No, all RGCC tests are currently ordered by registered provider. Our Customer Relations team is happy to provide you with providers in your area. Please contact us.

Does this test work for all cancer types?

Our tests can be utilized for all types of hematological and solid cancers, at various stages, outside of brain tumors because of the blood brain barrier not allowing the cells into general circulation.

Does insurance cover RGCC testing?

Unfortunately, at this time, none of our services are covered by insurance. 
The good news is that some offices may accept insurance to cover a portion of their in-office fees (such as blood draw fees, consultation fees, etc.).  We suggest inquiring with your RGCC Registered Provider to see if they accept any insurance. Your HSA may also cover RGCC services, however you will need to inquire with your HSA directly.

Where can I find studies done on RGCC Testing and Therapies?

Please see our published research articles, here: https://rgcc-international.com/published-articles/

My doctor is not in your network. Can they still order this test for me?

To order an RGCC test or therapy, the doctor must be registered with RGCC.  To become an RGCC provider, please have your doctor visit https://myrgcc.com/contact-us/ and someone from our RGCC College team will contact them with next steps.

How long will my test results take to come back? 

All test results are posted to your RGCC provider's Portal approximately 2 weeks from the time the blood arrives at the lab (and 3-4 weeks for aCGH tests). Once your results are available, your provider will reach out to you to review and interpret your results.

How do I know what test is right for me?

All our accredited practitioners are trained to guide you through the testing options and will make recommendations that are right for you.

What if the treatment doesn't work for me?

The power of our monitoring tests is they give you a measure of whether a treatment option is working or not so you can change course if needed. Along with the Onconomics panels which provide information about personalized treatment options, you have information on options that may be more effective for you.

How often should I see my practitioner about my cancer?

Each patient is unique. How often you should see your practitioner must be decided in consultation with them after they have reviewed your case. Although this timing may vary based on factors such as treatment options, within our process, monitoring is recommended every 3 months with active cancer to monitor effectiveness of treatments, and every 6-12 months in remission to monitor for early signs of recurrence as part of your Recurrence Prevention Program.

I was in remission, why did my cancer come back?

Even when you receive the “all clear” from your Oncologist, there may be CSCs (Circulating Stem Cell-like Cells) also known as TICs (Tumor Initiating Cells) still active and in circulation but at a level below the sensitivity of standard-of-care monitoring tests, such as imaging and physiological cancer marker testing. 

This means active cancer cells may be present, but they cannot be detected via traditional means until the cancer has grown big enough to be detected again. This leaves you vulnerable and without treatment because in the standard-of-care model, if you can’t see it, you can’t treat it, enabling the cancer to come back.

TIC monitoring with our OncoTrace and OncoTrail allows you to monitor these cells on a microscopic level allowing you to continue care until these cells are no longer active or if in remission, allowing you to see new activity as soon as it starts.

Is cancer more aggressive when it returns?

Cancer is often more aggressive when there is a recurrence. This highlights the importance of having a Recurrence Prevention Program once the cancer has gone into remission or as part of your post-treatment aftercare. 

Standard-of-care monitoring tests are not sensitive enough to detect early-stage recurrence activity. This allows cancer to take hold before it is detected, making it harder to treat. If you can’t see it, you can’t treat it. 

At RGCC, our OncoCount, OncoTrace, and OncoTrail monitoring tests detect the presence of cancer cells on a microscopic level, allowing for the earliest detection and treatment of recurrence allowing for a proactive, rather than reactive approach to care.

Is cancer contagious?

No. Cancer is not contagious and cannot be passed from one person to another.

How do I find an accredited provider?

Our team at RGCC North America is happy to provide you with a list of accredited providers. Simply fill out the contact form and our team will begin building your personalized referral list.

How do I order a blood draw kit?

Blood draw kits can only be ordered by our accredited practitioner. Simply fill out the contact form and our team will begin building your personalized referral list. 

Follow Us
Accreditations
IAS Accreditation
Testing Laboratory
View TL-836 Certificate
EN ISO 22000: 2018
No: 20101200002689
View Certificate
IAS Accreditation
Medical Laboratory
View ML-103 Certificate
ISO 22000: 2018
No: 20101200002689
View Certificate
ISO 45001: 2018
No: 20152220006395
View CertificatePolicy
ISO 22716: 2007
No: 20019220006394
View Certificate
CLIA ID Number
99D2283882
View Certificate
College of American Pathologists 
Certificate of Accreditation
CAP#: 9239089 
CLIA#: 99D2283882 
View Certificate
Certificate of GMP Compliance
No. 512863-102689104
View Certificate
Accreditation Certificate of Foreign Cell Processor - Japanese Government
View Certificate
EOF GMP COSMETICS – SUPPLEMENTS
View Certificate
Accreditations
IAS Accreditation
Testing Laboratory
View TL-836 Certificate
EN ISO 22000: 2018
No: 20101200002689
View Certificate
IAS Accreditation
Medical Laboratory
View ML-103 Certificate
ISO 22000: 2018
No: 20101200002689
View Certificate
ISO 45001: 2018
No: 20152220006395
View CertificatePolicy
ISO 22716: 2007
No: 20019220006394
View Certificate
CLIA ID Number
99D2283882
View Certificate
College of American Pathologists 
Certificate of Accreditation
CAP#: 9239089 
CLIA#: 99D2283882 
View Certificate
Certificate of GMP Compliance
No. 512863-102689104
View Certificate
Accreditation Certificate of Foreign Cell Processor - Japanese Government
View Certificate
EOF GMP COSMETICS – SUPPLEMENTS
View Certificate
Call
Text
Email
Map